Brief: Chugai Pharmaceutical says waiver of claims in patent infringement lawsuit

Nippon Kayaku Co

11/04/2018 07:47

April 11 (Reuters) - Chugai Pharmaceutical Co Ltd  4519.T  
   
    * Says it has decided to waive its claim in a patent
infringement
lawsuit against Nippon Kayaku Co Ltd  4272.T  
    * Says co filed a lawsuit to the Tokyo District Court on
Aug. 17,
2017, demanding the suspension of manufacturing and distribution
of the biosimilar of anti-HER2 monoclonal antibody Herceptin®
Injection 60 and 150 (Herceptin® Injection) against Nippon
Kayaku, the applicant for marketing approval of the biosimilar
of Herceptin® Injection, citing such party's infringement of the
application patents for the treatment of breast cancer owned by
Genentech Inc

    Source text in Japanese: https://goo.gl/7AQ1Qc
    Further company coverage: 4519.T  4272.T 

 (Beijing Headline News)
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: Tingting.liu@thomsonreuters.com@reuters.net))